arrow
Back
A

Ahmed O. Kaseb

The University of Texas MD Anderson Cancer Center

67H-index
548Paper Count
2.6WCitation Count
Published Papers 159
Publication Date
Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancer
errCancers
IF4.4
err2026-06-11
err0
errOAAI
errMakenna A. Smack; Jane E. Rogers; Lianchun Xiao; Sunyoung S. Lee; Shubham Pant; Ahmed O. Kaseb; Brandon G. Smaglo; Victoria Higbie; Zishou Ian Hu; Amy An; Milind Javle
errShare
errSave
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response
err2025-12-12
err0
errOAAI
errBrian De; Prashant Dogra; Mohamed Zaid; Dalia Elganainy; Kevin Sun; Ahmed M. Amer; Charles Wang; Michael K. Rooney; Enoch Chang; Hyunseon C. Kang; Zhihui Wang; Priya Bhosale; Bruno C. Odisio; Timothy E. Newhook; Ching-Wei D. Tzeng; Hop S. Tran Cao; Yun S. Chun; Jean-Nicholas Vauthey; Sunyoung S. Lee; Ahmed Kaseb; Kanwal Raghav; Milind Javle; Bruce D. Minsky; Sonal S. Noticewala; Emma B. Holliday; Grace L. Smith; Albert C. Koong; Prajnan Das; Vittorio Cristini; Ethan B. Ludmir; Eugene J. Koay
errShare
errSave
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma
err2025-12-10
err0
errOAAI
errJoe R Eid; Merih Yalciner; Lianchun Xiao; Ryan Sun; Mahesh Kumar Kannan; Manal Hassan; Asif Rashid; Shadi Chamseddine; Hop S Tran Cao; Hesham M Amin; Ahmed O Kaseb
errShare
errSave
Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma
err2025-11-01
err0
errOAAI
errEid, Joe; Haddad, Antony; Hassan, Manal; Amin, Hesham M.; Newhook, Timothy E.; Chun, Yun Shin; Tzeng, Ching-Wei D.; Vauthey, Jean-Nicolas; Cao, Hop S. Tran; Kaseb, Ahmed O.
errShare
errSave
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic Biomarker in Hepatocellular Carcinoma
err2025-10-01
err0
PREAI
errEid, Joe R.; Yalciner, Merih; Xiao, Lianchun; Sun, Ryan; Kannan, Mahesh Kumar; Hassan, Manal; Rashid, Asif; Singer, Emad; Amin, Hesham M.; Kaseb, Ahmed O.
errShare
errSave
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications
err2025-09-29
err0
errOAAI
errServando Hernandez Vargas; Solmaz Aghaamiri; Jack T. Adams; Tyler M. Bateman; Belkacem Acidi; Sukhen C. Ghosh; Vahid Khalaj; Ahmed O. Kaseb; Hop S. Tran Cao; Majid Momeny; Ali Azhdarinia
errShare
errSave
Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits
err2025-09-27
err0
errOAAI
errYounghun Han; Vikram R. Shaw; Jinyoung Byun; Aaron P. Thrift; Catherine Zhu; Donghui Li; Rikita I. Hatia; Robin Kate Kelley; Sean P. Cleary; Anna S. Lok; Paige M. Bracci; Jennifer B. Permuth; Roxana Bucur; Jennifer Knox; Jian-Min Yuan; Amit G. Singal; Prasun K. Jalal; R. Mark Ghobrial; Yuko Kono; Dimpy P. Shah; Mindie H. Nguyen; Neehar D. Parikh; Richard Kim; Hui-Chen Wu; Hashem El-Serag; Ping Chang; Yun Shin Chun; Jian Gu; Chad Huff; Asif Rashid; Lu-Yu Hwang; Alison P. Klein; Saira A. Khaderi; Ahmed O. Kaseb; Kathrine A. McGlynn; Lewis R. Roberts; Manal M. Hassan; Christopher I. Amos
errShare
errSave
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular Carcinoma
err2025-09-27
err1
PREAI
errAkyildiz, Arif; Yavuz, Betul Gok; Ismayilov, Rashad; Buyukaksoy, Muge; Sozen, Sena; Eid, Joe Ramzi; Avritscher, Rony; Sunyoung, Lee; Yalcin, Suayib; Kaseb, Ahmed O.
errShare
errSave
errShare
errSave
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial (vol 30, pg 807, 2024)
err2025-02-27
err0
errOAAI
errYim, Sun Young; Lee, Sung Hwan; Baek, Seung-Woo; Sohn, Bohwa; Jeong, Yun Seong; Kang, Sang-Hee; Park, Kena; Park, Hyewon; Lee, Sunyoung S.; Kaseb, Ahmed O.; Park, Young Nyun; Leem, Sun-Hee; Curran, Michael A.; Kim, Ji Hoon; Lee, Ju-Seog
errShare
errSave
Outcomes of durvalumab with or without tremelimumab in routine clinical practice according to HIMALAYA Trial Eligibility: preliminary results of the international DT-real study
err2025-02-01
err0
PREAI
errCelsa, C.; Nishida, N.; Chamseddine, S. M.; Arvind, A.; Li, M.; Toyoda, H.; Ulahannan, S.; Fulgenzi, C. A. M.; Manfredi, G. F.; D'Alessio, A.; Stefanini, B.; Cabibbo, G.; Camma, C.; Scheiner, B.; Rimassa, L.; Kelley, R. K.; Singal, A. G.; Kaseb, A. O.; Kudo, M.; Pinato, D. J.
errShare
errSave
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
err2025-02-01
err0
errOAAI
errFinn, Richard S.; Iyer, Renuka; Kalman, Richard S.; Parikh, Neehar D.; Cabrera, Roniel; Babajanyan, Svetlana; Kaseb, Ahmed O.
errShare
errSave
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus
err2025-01-01
err0
errOAAI
errHatia, Rikita I.; Hwang, Lu-Yu; Li, Ruosha; Troisi, Catherine; Jalal, Prasun K.; Amos, Christopher I.; Gomez, Henry F.; Chun, Yun Shin; Rashid, Asif; Kaseb, Ahmed O.; Scheet, Paul A.; Hassan, Manal M.
errShare
errSave
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma
err2024-10-30
err0
errOAAI
errDeAzevedo, Ricardo; Steiner, Madeline; Turner, Broderick X.; Liu, Arthur; Newton, Sherwin; Schmidt, Joanna; Fleming, Rachel; Tolentino, Angelica; Kaseb, Ahmed O.; Curran, Michael A.
errShare
errSave
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
err2024-10-01
err1
errOAAI
errYim, Sun Young; Lee, Sung Hwan; Baek, Seung-Woo; Sohn, Bohwa; Jeong, Yun Seong; Kang, Sang-Hee; Park, Kena; Park, Hyewon; Lee, Sunyoung S.; Kaseb, Ahmed O.; Park, Young Nyun; Leem, Sun-Hee; Curran, Michael A.; Kim, Ji Hoon; Lee, Ju-Seog
errShare
errSave
Analysis of antidrug antibodies (ADA) to camrelizumab in CARES-310: The pivotal phase III study of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma (uHCC)
err2024-09-01
err0
PREAI
errKaseb, A. O.; Bugni, J.; Karkhanis, M.; Meng, X.; Wei, T.; Zhou, M.; Shen, K.; Yang, C.; Yu, M.; Jang, S. H.; Ryan, K.; Alexander, L.
errShare
errSave
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
err2024-08-02
err2
errOAAI
errDogra, Prashant; Shinglot, Vrushaly; Ruiz-Ramirez, Javier; Cave, Joseph; Butner, Joseph D.; Schiavone, Carmine; Duda, Dan G.; Kaseb, Ahmed O.; Chung, Caroline; Koay, Eugene J.; Cristini, Vittorio; Ozpolat, Bulent; Calin, George A.; Wang, Zhihui
errShare
errSave
Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma
err2024-05-24
err4
errOAAI
errAbdelrahim, Maen; Esmail, Abdullah; Divatia, Mukul K.; Xu, Jiaqiong; Kodali, Sudha; Victor, David W.; Brombosz, Elizabeth; Connor, Ashton A.; Saharia, Ashish; Elaileh, Ahmed; Kaseb, Ahmed O.; Ghobrial, Rafik Mark
errShare
errSave